Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-21

FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's supplemental application for nevirapine, expanding the availability of this antiretroviral generic. The approval covers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)